Prediction of hydroxyurea effect on sickle cell anemia patients using machine learning method

B.K. Singh, A. Ojha, K.K. Bhoi, A. Bissoyi, P.K. Patra

Research output: Chapter in Book/Conference proceedingConference contributionpeer-review

Abstract

The objective of this paper is to predict the effect of hydroxyurea of individuals suffering from Sickle Cell Disease (SCD) using predictive machine learning techniques. Nowadays worldwide sickle cell disease becomes the most common inherited disease, which remains associated with long life morbidity and makes life expectancy low or we can say it reduces the lifespan of the concerned person. To overcome such diseases, a chemotherapeutic drug Hydroxyurea is taken by the concerned patient to re-mediate clinical problems of sickle cell disease. This paper discusses the use of a machine learning approach to predict the effects of the drug Hydroxyurea (HU) treatment in different sickle cell anemic patients. Fetal hemoglobin before and after treatment of HU establishes the basis for classification. Support vector machine has been used for classification and the dataset is rigorously analyzed for different data division methods and we got the maximum accuracy level of 94%.
Original languageEnglish
Title of host publicationAdvances in Biomedical Engineering and Technology
Subtitle of host publicationSelect Proceedings of ICBEST 2018
EditorsAlbert A. Rizvanov , Bikesh Kumar Singh , Padma Ganasala
PublisherSpringer Nature
Pages447–457
Number of pages11
ISBN (Electronic)9789811563294
ISBN (Print)9789811563287
DOIs
Publication statusPublished - 29 Sept 2020

Publication series

NameLecture Notes in Bioengineering
NameICBEST: International Conference on Biomedical Engineering Science and Technology

Keywords

  • Sickle cell anemia
  • Hydroxyurea
  • Support vector machine

Fingerprint

Dive into the research topics of 'Prediction of hydroxyurea effect on sickle cell anemia patients using machine learning method'. Together they form a unique fingerprint.

Cite this